Enrolling by invitationPhase 4NCT03654066

Botox or Botox With Esophageal Dilation in Patients With Achalasia

Studying Idiopathic achalasia

Last synced from ClinicalTrials.gov

Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing data

Key facts

Sponsor
Vanderbilt University Medical Center
Principal Investigator
Dhyanesh Patel, MD
Vanderbilt University Medical Center
Intervention
Botulinum toxin type A(drug)
Enrollment
50 target
Eligibility
18 years · All sexes
Timeline
20192026

Study locations (1)

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT03654066 on ClinicalTrials.gov

Other trials for Idiopathic achalasia

Additional recruiting or active studies for the same condition.

See all trials for Idiopathic achalasia

← Back to all trials